In This Section

Home / Learn / Publications / Patient Assistance and Reimbursement Guide

Patient Assistance and Reimbursement Guide

Updated January 2019

The 2019 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment. This guide contains directions on program enrollment for more than 130 medications, granting insured, underinsured, and uninsured patients access to oncology drugs at little or no cost. The January 2019 update contains:

  • Pharmaceutical patient assistance and co-pay programs, including new programs from Regeneron Pharmaceuticals and Sanofi Genzyme
  • Not-for-profit and foundation patient assistance and co-pay programs
  • Directions on how to apply and links to enrollment forms
  • Patient assistance flow charts for specific patient populations
  • Valuable advice from Natasha Gomes, financial navigator at DuPage Medical Group, on optimizing your electronic health record (EHR) to improve workflow, reduce patient expense, and increase assistance program enrollment.

Print copies of the 2019 Patient Assistance & Reimbursement Guide will be mailed to ALL current ACCC members.

Email your comments and feedback to Will True, Writer/Editor, ACCC at

Other Financial Advocacy Resources

Our Financial Advocacy Boot Camp offers a dynamic online curriculum that helps you and your cancer patients navigate the complex healthcare system and pay for their treatment. Learn more about how to be an effective financial advocate.

Learn More

The ACCC Oncology Drug Database contains billing and diagnosis codes, reimbursement amounts, FDA-approved indications, and contact information for every cancer drug on the market.

Access the Database


begin-quoteThe guide is so important to my job and I have helped so many patients as a result. I cannot thank you enough for having this extremely helpful information in one place.

Bonnie Snead
Insurance Authorization Manager
Inova Hematology Oncology
Fairfax, VA end-quote


SITC - Advances in Cancer Immunotherapy